CSTE Overdose Anomaly Toolkit: Prescribing Systems

Prescribing Systems

Last Updated: March 2022

Prescription Drug Monitoring Programs (PDMP)

54 operational prescription drug monitoring programs (PDMP) exist in the United States (49 states; St. Louis County, Missouri; the District of Columbia; and three U.S. territories—Guam, the Northern Mariana Islands, and Puerto Rico). These systems can provide critical information to investigations. However, state PDMP data may be difficult to access due to state laws. Twenty-nine states were funded by CDC through the Prevention for States funding to maximize the use of PDMPs and collect indicators of opioid prescriptions.  An additional 13 states and the District of Columbia were funded by CDC through the Data-Driven Prevention Initiative (DDPI) to improve data collection related to opioid use and overdose, including PDMP data. Through supplemental drug overdose opioid funding, CDC supports additional PDMP data integration activities with mortality data and health information exchanges through programs such as Overdose Data To Action . Indicator data from these projects and data sharing relationships with PDMPs built under this project may be useful to inform response efforts. 

MMWR published a surveillance summary of data collected by eight state PDMP systems.  The summary provides insight into possible key indicators to track as part of the response effort. 

IQVIA

IQVIA is a U.S. company that provides nationwide physician prescribing data.  CDC has access to the projected number of new and total prescriptions as well as the projected number of extended units for these prescriptions at the national, state, and county level.  U.S. Opioid Prescribing Rate Maps based on IQVIA data are available here 

CDC published a MMWR Vital Signs, Changes in Opioid Prescribing in the United States, 2006–2015, and a JAMA article County-Level Opioid Prescribing in the United States, 2015 and 2017 using IQVIA data.  CDC’s annual surveillance summary provides detailed information on opioid-related prescribing using IQVIA data.  The surveillance summary also includes hospitalization, use and misuse, and mortality data.  

Toolkit Resources

Get more insights by using our toolkit resources.
Go to Resources

Glossary

Learn the definition of the key words being used.
Go to Glossary

Thanks

Thank you, to all of our contributors.
View our contributors

CSTE white logo
Using the power of epidemiology to improve
the public’s health.

Contact Us

Have any questions or recommendations, you can contact us at overdose@cste.org